This site uses cookies to enhance your experience. By continuing to browse you accept our Cookie Policy.
European Medicines Agency building exterior sign

REGULATORY

12 Feb 2026

mRNA Makers Face a More Exacting Europe

Draft guidance signals tougher standards for mRNA vaccines and a shift toward long-term regulatory rigor

Biopharmaceutical manufacturing facility supporting RNA drug production

INNOVATION

6 Feb 2026

From Concept to Clinic, Circular RNA Faces Its Test

A December 2025 deal between Circurna and uBriGene highlights how circular RNA is shifting from promise to production

BioNTech company logo displayed on the exterior of a modern office building

TECHNOLOGY

4 Feb 2026

Algorithms Are Now Europe’s Hottest Biotech Talent

By 2025, AI is speeding up mRNA design and redrawing biotech’s competitive lines across Europe

CureVac headquarters sign as company agrees to acquisition by BioNTech

PARTNERSHIPS

8 Dec 2025

Can BioNTech’s CureVac Deal Spark a Biotech Revival?

BioNTech’s $1.25bn acquisition of CureVac brings two early mRNA pioneers together as Europe seeks scale in a competitive global market

Thermo Fisher Scientific logo as company partners on mRNA development

PARTNERSHIPS

3 Dec 2025

A Power Partnership Pushes Europe’s mRNA Ambitions

Ethris and Thermo Fisher team up to scale stable mRNA innovations and advance the SNIM RNA platform

Illustration showing mRNA strand linking Covid vaccines to cancer therapies

MARKET TRENDS

24 Oct 2025

From Covid to Cancer, Europe’s mRNA Strategy Takes Shape

Targeted funding and new facilities show a steady push to extend mRNA science beyond Covid-era vaccines

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.